Get the Stockscreener App
5.625
1.83%
-0.105
After Hours:
5.63
0.005
+0.09%
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $5.625, with a volume of 1.96M.
It is down -1.83% in the last 24 hours and down -0.62% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
See More
Previous Close:
$5.73
Open:
$5.75
24h Volume:
1.96M
Relative Volume:
0.78
Market Cap:
$2.08B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-11.72
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
-7.94%
1M Performance:
-0.62%
6M Performance:
-21.98%
1Y Performance:
-19.76%
1-Day Range:
$5.565
$5.77
1-Week Range:
$5.565
$6.095
52-Week Range:
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
5.625 | 2.12B | 9.47B | -178.00M | 1.01B | -0.48 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.98 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.48 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.88 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Bausch Health (NYSE: BHC) CFO reports tax-withholding share disposition - Stock Titan
Bausch Health (BHC) EVP Carson trades shares, settles equity awards - Stock Titan
Tax withholding and cash PSU settlement for Bausch Health (BHC) CEO - Stock Titan
Seana Carson reports sales of 8,388 and 6,856 shares — BHC (NYSE: BHC) - Stock Titan
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs - Investing.com Canada
Bausch Health updates executive compensation agreements to cash settlement for 2023 PSUs By Investing.com - Investing.com Australia
Bausch Health (NYSE: BHC) converts 2023 executive PSUs into cash-settled awards - Stock Titan
Bausch Health (NYSE:BHC) Stability Story Amid Canada Pharma Shifts Nyse Composite Today - Kalkine Media
Proposed insider sale at BHC (NYSE: BHC) — 6,856 common shares - Stock Titan
Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Reduce" from Analysts - MarketBeat
Bausch Health Marks Arestin Milestone And Highlights Niche Dental Opportunity - Sahm
Is Bausch Health (BHC) Pricing Reflect Its Sharp Multi‑Year Share Price Declines? - Sahm
Assessing Bausch Health (BHC) Valuation After Years Of Weak Returns And Ongoing Debt Reduction Efforts - Sahm
Bausch Health (BHC) SVP Steven Lee receives 45,868 restricted share units - Stock Titan
Bausch Health (NYSE: BHC) EVP receives RSU grant, tax shares withheld - Stock Titan
Insider moves at Bausch Health (BHC): RSU grant, tax shares, open-market sale - Stock Titan
Bausch Health (NYSE: BHC) CFO awarded RSUs; shares withheld for tax obligations - Stock Titan
Should Bausch Health’s Profit Return and 2026 Outlook Shift the Investment Case for BHC? - Yahoo Finance
BHC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bausch Health Cos (NYSE:BHC) Price Target Cut to $7.00 by Analysts at Barclays - MarketBeat
Signal Recap: Is now the right time to enter SAIAQuarterly Market Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
EV Market: Is Bausch Health Companies Inc backed by strong institutional buyingMarket Volume Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Bausch Health (NYSE: BHC) CEO granted 815K RSUs, 116K shares withheld for tax - Stock Titan
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors - DirectorsTalk Interviews
Trading Recap: Is Bausch Health Companies Inc stock a value trapJuly 2025 Gainers & Free Community Consensus Stock Picks - baoquankhu1.vn
Separation Overhang Continues to Weigh on Bausch Health Companies Inc. (BHC) Outlook - Insider Monkey
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada - PR Newswire
New anti-aging laser lets Canadian clinics target wrinkles, spots, pores - Stock Titan
Bausch Health Weighs China Aesthetics Push Against ARESTIN Milestone And Debt - Yahoo Finance
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Fennec Pharmaceuticals (FENC) and InfuSystem Holdings (INFU) - The Globe and Mail
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? - sharewise.com
Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV), Bausch Health Companies (BHC) and Insulet (PODD) - The Globe and Mail
Bausch Health Companies Inc. (NYSE:BHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Can Bausch Health Companies Inc expand into new markets2025 Trade Ideas & Weekly Sector Rotation Insights - baoquankhu1.vn
Bausch Health revenue by segment 2021-2024 - Statista
Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats (NYSE:BLCO) - Seeking Alpha
BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - Finviz
Bausch Health Cos (NYSE:BHC) Shares Gap DownTime to Sell? - MarketBeat
How Bausch Health’s Turnaround Progressed In Q4 2025 (NYSE:BHC) - Seeking Alpha
Bausch Health Companies Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres - Yahoo Finance
Will Bausch Health Companies Inc announce a stock splitQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Bausch Health Companies Inc (BHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Bausch Health expects 3% revenue growth in 2026 while strengthening balance sheet and expanding in China - MSN
A Look At Bausch Health Companies (BHC) Valuation After Mixed Quarterly Results And China Expansion - Sahm
Bausch Health (BHC) Q4 2025 Earnings Transcript - The Globe and Mail
Bausch Health Cos Q4 Earnings Call Highlights - Yahoo Finance
Bausch Health (BHC) Q4 Earnings Lag Estimates - Yahoo Finance
Here's What Key Metrics Tell Us About Bausch (BHC) Q4 Earnings - Nasdaq
Bausch: Q4 Earnings Snapshot - kens5.com
Bausch Health Cos (NYSE:BHC) Releases Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):